Here are five things to know:
1. Stryker acquired Stanmore for £35.6 million, or around $41 million, in an all-cash transaction.
2. Stanmore focuses on orthopedic oncology implants. The company includes patient-specific and off-the-shelf implants for limb salvage.
3. The acquisition will differentiate technologies for Stryker and underscore the company’s commitment to the core joint replacement business as well as expand Stryker’s presence in the global orthopedic oncology market.
4. Stryker has been acquiring several companies over the past few months, including closing the acquisition on CareFusion’s vertebral compression fracture product portfolio on April 21 and SafeWire’s product portfolio on April 11.
5. Stryker reported 4.9 percent net sales growth to $2.5 billion for the first quarter of 2015 and a net earnings increase of 79.5 percent to $402 million. The company is expecting 2016 organic sales growth in the range of 5.5 percent to 6.5 percent.
More articles on orthopedic devices:
Zimmer Biomet, NuVasive, Wenzel Spine & more: 21 key notes
K2M hosts spine surgeons at 2016 Meeting of Minds
Life Spine to host physician workshop for new solutions launching in 2016
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
